EP3400947

IONIS PHARMACEUTICALS, INC.
Application Number
EP18179911A
Filing Date
Feb 14, 2014
Status
Granted And Under Opposition
Jul 21, 2023
Grant Date
Aug 23, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3400947B1 was granted on Aug 23, 2023 by Ionis Pharmaceuticals, Inc. The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AMMELBURG, MORITZMay 22, 2024ADMISSIBLE

The table below shows the patents of Ionis Pharmaceuticals, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2906696Methods For Modulating C9Orf72 ExpressionDec 14, 20222
EP3461895Modulation Of Ube3A-Ats ExpressionJul 1, 20201
EP2742135Linkage Modified Gapped Oligomeric Compounds And Uses ThereofJun 10, 20201